Clinical studies of extended-half-life recombinant FVIII products for prophylaxis in adults and children: A critical review from the physician's perspective - Hermans, C; Reding, M T; Astermark, J; Klamroth, R; Mancuso, M E (Crit Rev Oncol Hematol, 2022)